Detalhe da pesquisa
1.
An ultrapure plasma-derived monoclonal antibody-purified factor IX concentrate (Nonafact®), results of phase III and IV clinical studies.
Haemophilia;
17(3): 439-45, 2011 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21362109
2.
Factor VIII genotype and inhibitor development in patients with haemophilia A: highest risk in patients with splice site mutations.
Haemophilia;
14(4): 729-35, 2008 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18503540
3.
Misleading one-stage coagulation factor assay during rFVIIa treatment in lupus patient.
Haemophilia;
15(5): 1164-6, 2009 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19601985
4.
A clinical and cardiovascular survey of Ehlers-Danlos syndrome patients with complete deficiency of tenascin-X.
Neth J Med;
62(5): 160-2, 2004 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15366699
5.
In vivo recovery and safety of human factor VIII product AAFACT in patients with haemophilia A.
Haemophilia;
9(2): 157-63, 2003 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12614366